Sunday, June 21, 2026

The ABSURD Bet: Carney Dares Trump to Wager Tariffs on Baseball, But the President Is Too Scared to Lose

Canadian PM Carney challenges Trump to a wager on the World Series, predicting a Blue Jays win amid U.S.-Canada tensions.

Pyongyang’s Outrage: North Korea Slams U.S. for Human Rights Discussions

North Korea condemns US-South Korea talks on human rights, calling it a conspiracy and warning against threats to its sovereignty.

OIL AS A HOSTAGE : Why Trump Just Threatened To Seize The Strait Of Hormuz To Save Your Gas Prices

U.S. stocks surged as oil prices dropped after G7 ministers considered releasing reserves and Trump discussed military control of Hormuz.

Health

Moxidectin vs. Traditional Heartworm Preventatives: Which Offers Better Protection in 2026?

Reports of drug resistance in heartworm prevention highlight the need for moxidectin-based strategies to combat ML-resistant strains.

Predicting Parkinson’s Progression: How Genetic Insights Can Transform Patient Care in 2026

New research reveals potential for predicting Parkinson's disease progression and developing personalized treatment strategies for patients.

Unlocking the Secrets of Letybo: How Korea’s Leading Botulinum Toxin is Capturing 20% of China’s Market

Hugel successfully held a Letybo symposium in Chengdu, enhancing medical aesthetics knowledge among over 100 Chinese professionals.

Seoul Asan Hospital Dominates Newsweek’s 2026 Asia-Pacific Rankings: 5 Clinical Areas at #1!

Seoul Asan Medical Center ranks first in five specialties in Newsweek's 2026 Asia-Pacific Best Hospitals, showcasing its medical excellence.

Matica Bio Launches Open Access Platform: A Game Changer for Gene Therapy in 2026

Matica Bio launches an open CDMO platform for gene therapy, enhancing client control and streamlining production with Cirsium Biosciences.
Latest

How AI-Powered Ultrasound is Transforming Cardiovascular Diagnosis in Asia

UltraSight and Mediana collaborate on an AI-driven cardiovascular diagnostic platform, enhancing patient monitoring and disease management.

How Samsung’s On-Device AI is Transforming Emergency Ultrasound Diagnostics in 2026

Samsung Medical Center is developing AI ultrasound tech for emergency care, enhancing diagnostics with real-time, on-device capabilities.

Noel Wins Government Backing to Accelerate Expansion in Europe and Latin America

Noel, an AI diagnostics firm, joins South Korea's Global SME 1000+ Project to enhance global expansion and strengthen market presence.

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Can Donanemab Expand Alzheimer’s Treatment to Lewy Body Dementia? Key Insights from Korean Lilly’s Latest Clinical Trials

Lilly has launched a global trial for Kisunla, targeting Lewy body dementia, aiming to expand its Alzheimer's treatment to this underserved area.

CT-P72/ABP-102: The Next Big Breakthrough in HER2 Cancer Treatment?

Celltrion's CT-P72/ABP-102 shows strong efficacy against HER2 tumors, promising for treating various cancers with reduced toxicity.

Revolutionary AI Solution by Seers Detects Abnormal Signals in Patient Monitoring: What You Need to Know

Seers announces AI breakthrough for detecting abnormal signals in patient monitoring, enhancing clinical decision support and patient care.

How Angeliq and Other Treatments Are Transforming Menopausal Care in 2026

Daewon Pharmaceutical's symposium focused on menopausal hormone therapy, featuring discussions on Angeliq and recent clinical findings.

How Hyundai BioScience’s XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

Hyundai Bio USA proposes to provide antiviral candidate XAFTY for free to Ebola-affected countries, aiming to combat the disease urgently.

Coronary Intravascular Lithotripsy Gains Attention as Safer Alternative for Heavily Calcified Arteries

Kyung Hee University Hospital's cardiology team uses coronary intravascular lithotripsy to treat severe calcified coronary artery disease in elderly patients.

Onconic Therapeutics Licenses GERD Drug Zaqubo to Indonesia’s Dexa Medica

Onconic Therapeutics partners with Dexa Medica to commercialize GERD treatment Zaqubo in Indonesia, enhancing its global expansion strategy.

Huons Group Hosts Chinese Medical Delegation to Expand Healthcare and Aesthetics Collaboration

Huons Group has established a platform for medical exchange between Korea and China, leveraging its unique technology in the global aesthetic market.

Can GLP-1 Medications Reduce Breast Cancer Risk? New Research Reveals Surprising Findings

GLP-1 drugs show promise in cancer prevention and progression inhibition, expanding beyond obesity treatment to chronic disease management.

How International Collaboration is Revolutionizing Infectious Disease Research in Asia

Korea's Disease Control Agency establishes a framework for local medical institutions to join international clinical trials for infectious diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.